Moonlight Therapeutics is focused on developing safe, effective, and patient-friendly treatments for food allergies.
Moonlight Therapeutics has raised $2.4M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in August 2024.
Moonlight Therapeutics's investors include SeedToB Capital, National Institute of Allergy and Infectious Diseases, Central Piedmont Investment Group.
Moonlight Therapeutics is headquartered in Atlanta, United States.
Moonlight Therapeutics is focused on developing safe, effective, and patient-friendly treatments for food allergies.
Moonlight Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Moonlight Therapeutics — Funding & Investors." VCBacked, August 15, 2024, https://www.vcbacked.co/company/moonlight-therapeutics. Accessed September 30, 2026.
VCBacked. (2024). Moonlight Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/moonlight-therapeutics
{{cite web |title=Moonlight Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/moonlight-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated